Clinical Trial Update: Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intensive versus moderate lipid-lowering therapy in patients after myocardial infarction. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Odense University Hospital | Conditions: Myocardial Infarction [C14.907.585.500] | Phase 4 | Status: COMPLETED